Articles published by Alzamend Neuro, Inc.![]() ![]()
Alzamend Neuro Has Regained Compliance with Nasdaq's Minimum Bid Price Requirement
September 22, 2022
From Alzamend Neuro, Inc.
Via Business Wire
Tickers
ALZN
![]() ![]() ![]()
Alzamend Neuro Reports Third Fiscal Quarter Financial Results and Provides a Business Update
March 16, 2023
From Alzamend Neuro, Inc.
Via Business Wire
Tickers
ALZN
![]()
Alzamend Neuro to Present at Sequire Biotechnology Conference
January 26, 2023
From Alzamend Neuro, Inc.
Via Business Wire
Tickers
ALZN
![]() ![]() ![]()
Alzamend Neuro CEO Stephan Jackman to Appear on Fox Business Network to Discuss Therapeutic Pipeline
November 15, 2022
From Alzamend Neuro, Inc.
Via Business Wire
Tickers
ALZN
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]()
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|